Molecular Testing Improves Nodular Fasciitis Diagnosis - Summary - MDSpire
From the Journals

Molecular Testing Improves Nodular Fasciitis Diagnosis

USP6 analysis helps resolve uncertainty in atypical soft-tissue lesions

Share

A study identified USP6 rearrangements in all clinically non-specific nodular fasciitis cases from 29 patients, where many presented with alarming histologic features. The researchers performed a retrospective analysis, revealing that 66% of cases did not initially raise suspicion for nodular fasciitis, with some involving atypical locations. Molecular testing including fluorescence in situ hybridization and next-generation sequencing confirmed diagnosis, with atypical fusion partners noted in younger patients. These findings emphasize the importance of molecular diagnostics in recognizing non-classical presentations of nodular fasciitis.

Original Source(s)

Molecular Testing Improves Nodular Fasciitis Diagnosis

  • by Andrea Surnit

  • April 3, 2026

Related Content

Slide Analysis, Rebuilt for Data Age

New platform links histology with molecular data for integrated pathology workflows

  • April 3, 2026

  • 3 min
Scanning New Horizons (in Digital Pathology)

How biomedical imaging technician Andrew Mullen championed the implementation of digital pathology across a large children's hospital

  • April 3, 2026

  • 5 min
ATM IHC Identifies POLE-Mutant Endometrial Cancer

Loss staining patterns help flag tumors for sequencing when molecular testing is limited.